English | Español

The Medicines Company
Nicholas Gueguen | Aug 22, 2017

The Medicines Company releases progress report for second quarter
Nicholas Gueguen | Jul 22, 2017

ORION-1 Phase II data shows promise for inclisiran
Caitlin Nordahl | Apr 22, 2017

The Medicines Company to highlight its antimicrobial products at conference in Austria
Gene Johnson | Apr 10, 2017

Medicines Co. webcast highlights clinical trial results of cholesterol-lowering drug
Kyle Perrotti | Mar 15, 2017

Conference call to review study of inclisiran

Gene Johnson | Mar 10, 2017

FDA accepts The Medicines Co.'s filing for urinary tract infection drug
Erianne Leatherman | Mar 3, 2017

FDA accepts priority application for urinary tract infection treatment
Keri Carbaugh | Jan 10, 2017

Meanwell presents at Morgan Healthcare Conference

Trending
+ Technology/Innovation
Patient Daily News Service | Oct 9, 2025

Babylon Health collapse raises questions about AI claims across industries
Patient Daily | Oct 9, 2025

Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
Patient Daily | Oct 9, 2025

AI takes center stage at ASCENT ENT conference, reshaping marketing and operations
+ Pharmaceuticals
Patient Daily | Oct 7, 2025

Patients Rising co-founder on 340B drug pricing program: ‘Patients are getting screwed when it comes to their collection practices’